Perturbations du comportement secondaires aux troubles neurocognitifs (SCPD) : Évaluation et prise en charge globale #111

Lyketsos, C. G., Sheppard, J. M., Steele, C. D., Kopunek, S., Steinberg, M., Baker, A. S., . . . Rabins, P. V. (2000). Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer’s disease: initial results from the Depression in Alzheimer’s Disease study. Am J Psychiatry, 157(10), 1686-1689. http://www.ncbi.nlm.nih.gov/pubmed/11007727